Metis Global Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
3,776
-401
-10% -$109K 0.02% 439
2025
Q4
$1.05M Sell
4,177
-139
-3% -$36.9K 0.02% 451
2025
Q3
$1.24M Sell
4,316
-205
-5% -$54.9K 0.03% 426
2025
Q2
$1.19M Sell
4,521
-553
-11% -$135K 0.03% 431
2025
Q1
$1.18M Buy
5,074
+620
+14% +$150K 0.03% 428
2024
Q4
$1.02M Buy
4,454
+22
+0.5% +$5.05K 0.03% 430
2024
Q3
$990K Buy
4,432
+72
+2% +$15.8K 0.03% 442
2024
Q2
$887K Buy
4,360
+160
+4% +$32.5K 0.03% 436
2024
Q1
$918K Sell
4,200
-72
-2% -$15.9K 0.03% 438
2023
Q4
$971K Sell
4,272
-356
-8% -$74.8K 0.04% 415
2023
Q3
$930K Buy
4,628
+148
+3% +$31.2K 0.05% 396
2023
Q2
$929K Buy
4,480
+200
+5% +$38.8K 0.05% 385
2023
Q1
$844K Buy
4,280
+1,964
+85% +$404K 0.05% 364
2022
Q4
$469K Buy
2,316
+613
+36% +$120K 0.04% 437
2022
Q3
$299K Buy
1,703
+16
+0.9% +$3.28K 0.05% 422
2022
Q2
$340K Sell
1,687
-75
-4% -$16K 0.05% 383
2022
Q1
$399K Buy
1,762
+778
+79% +$183K 0.05% 347
2021
Q4
$266K Buy
+984
New +$244K 0.07% 305

Other funds holding LH

Metis Global Partners's LH Position: Q1 2026 in Review

Metis Global Partners reduced its Labcorp (LH) stake by 9.6% in Q1 2026, selling an estimated $109K and leaving 3,776 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #439.

Metis Global Partners first reported a position in LH in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.24M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Metis Global Partners held 3,776 shares of Labcorp worth $1.01M as of Q1 2026.
  • Metis Global Partners sold 401 Labcorp shares in Q1 2026, an estimated $109K.
  • Labcorp made up 0.02% of Metis Global Partners's portfolio in Q1 2026, its #439 holding.
  • Metis Global Partners first reported a position in Labcorp in Q4 2021 and has held it in 18 quarters since.
  • Metis Global Partners's Labcorp position peaked at $1.24M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.